Jason Aryeh, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 5,000 shares at $250.00 ($1.3M) on 2026-06-10, disclosed to the SEC on 2026-06-12.
Seasonal sale ($1.2M) by Director — this insider has traded LGND in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $250.00 | 500 | $125K | 10.0% |
| 2 | $250.00 | 4,500 | $1.1M | 90.0% |
| Total | $250.00 avg | 5,000 | $1.3M | 100% |
| Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |
| LGND | BUY | 2019-09-04 | $131K | — | Filing → |